5,763 Shares in Waters Co. (NYSE:WAT) Bought by Lbp Am Sa

Lbp Am Sa bought a new position in shares of Waters Co. (NYSE:WAT) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 5,763 shares of the medical instruments supplier’s stock, valued at approximately $2,138,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Barclays PLC grew its stake in shares of Waters by 34.8% during the third quarter. Barclays PLC now owns 159,995 shares of the medical instruments supplier’s stock worth $57,579,000 after purchasing an additional 41,339 shares in the last quarter. Savant Capital LLC grew its stake in shares of Waters by 3.8% during the fourth quarter. Savant Capital LLC now owns 1,704 shares of the medical instruments supplier’s stock worth $632,000 after purchasing an additional 63 shares in the last quarter. Natixis Advisors LLC grew its stake in shares of Waters by 71.9% during the third quarter. Natixis Advisors LLC now owns 140,992 shares of the medical instruments supplier’s stock worth $50,742,000 after purchasing an additional 58,983 shares in the last quarter. Public Sector Pension Investment Board grew its stake in shares of Waters by 13.2% during the third quarter. Public Sector Pension Investment Board now owns 2,578 shares of the medical instruments supplier’s stock worth $928,000 after purchasing an additional 300 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. grew its stake in shares of Waters by 7.1% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 421,691 shares of the medical instruments supplier’s stock worth $156,439,000 after purchasing an additional 27,801 shares in the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Price Performance

Shares of NYSE:WAT opened at $378.18 on Friday. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14. The company has a market cap of $22.47 billion, a P/E ratio of 35.31, a PEG ratio of 3.79 and a beta of 1.00. Waters Co. has a 52 week low of $279.24 and a 52 week high of $423.56. The company has a 50-day moving average price of $391.24 and a 200 day moving average price of $370.28.

Waters (NYSE:WAT) last announced its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, beating analysts’ consensus estimates of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. Research analysts predict that Waters Co. will post 12.86 earnings per share for the current year.

Analysts Set New Price Targets

WAT has been the subject of several research analyst reports. Sanford C. Bernstein upgraded shares of Waters from a “market perform” rating to an “outperform” rating and set a $430.00 price objective for the company in a research note on Friday, January 10th. Wells Fargo & Company upped their price objective on shares of Waters from $415.00 to $420.00 and gave the company an “overweight” rating in a research note on Thursday, February 13th. Bank of America decreased their price objective on shares of Waters from $430.00 to $410.00 and set a “neutral” rating for the company in a research note on Thursday, February 13th. StockNews.com downgraded shares of Waters from a “buy” rating to a “hold” rating in a research note on Tuesday, February 25th. Finally, Barclays upgraded shares of Waters from an “underweight” rating to an “equal weight” rating and upped their price objective for the company from $360.00 to $415.00 in a research note on Monday, February 10th. Eleven research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $391.07.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.